We are experts in life science, biotechnology and medical technology, but also related areas such as ICT, eHealth and big data. Through our services we strive to contribute to the development of breakthrough products that serve an unmet medical need. We commit ourselves to design the highest quality projects and be successful in securing funding to realize our clients’strategic and business objectives.
We secure your non-dilutive funding, including large scale European grants. We take on the full application process using our proven approach.
We raise dilutive funding through our investor network, ideally suited to co‐finance your grant programs and fulfil your later stage capital needs.
400+ Mln euro raised
900+ Network partners
Team of consultants with scientific and academic excellence (PhD, MD)
Consultants with relevant commercial experience in translating research into commercial products
We use a step-wise approach and take full control over the application process, while keeping you informed about the process at all time. Catalyze become a true partner and is in the driver seat to maximize your funding results.
We define the best project concepts and solve any missing links to increase your chance of getting funded.
We design high quality work packages, including feasible and ealistic timelines, deliverables and milestones.
Weprovide detailed budget planning and draft the budgets for your project, including the budget of consortium members.
We facilitate grant and consortium agreements to ensure you can successfully start your project, including IP and exploitation articles. We can also provide project management services during your project.
We offer a network of >800 partners for consortium building. We actively seek and approach partners to join your project.
We take on the full writing of your proposals, and offer our strong knowledge to score on exploitation, impact, implementation and dissemination.
We coordinate the entire process, from project intake to successful submission. We also represent your consortium towards the funding agencies..
What client say about us
8-6-2017 By Clara Elbers Every scientist dreams of leading and winning a big H2020 project one day. Besides receiving a great amount of money to do research, it’s a prestigious affair and it can give your career a big boost. But how do you know if (and when) you are ready to be a H2020…
WBSO is a tax-deduction that is of major influence to the successful R&D projects of the Dutch LSH-sector. It drives innovations and enables companies in taking on riskier R&D-projects. Impact of WBSO on the LSH-sector In 2016, Catalyze performed a qualitative study to the impact of WBSO on the LSH-sector in the Netherlands. By conducting…
The biotechnology landscape is complex and defining a business strategy that will lead to success is challenging. Many companies struggle to define the roadmap towards success and to bridge the gap from being a start-up towards reaching an IPO, trade sale or launch onto the market of their product. Specifically, the lack of profit during…